LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged waiver · clear

Unsorted

Intellectual Property and Access to Medicine, Are Patents the Barrier?

Especially now with the COVID-19 vaccine patent waiver debate, it comes to our mind the relationship between patent system and access to medicine. As in all over fields where intellectual property protection exists, without appropriate patent protection…

August 6, 2021·Unsorted·1 min read
PTAB

PTAB Sovereign Immunity Dispute Heads to CAFC

Federal Circuit to Consider PTAB Sovereign Immunity Defense State-affiliated entities enjoy immunity from suit in federal courts under the 11th amendment. To date, a handful of such entities have successfully leveraged the same immunity theory to avoid…

February 15, 2018·PTAB·2 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data